Advances Help Researchers To See The Cornea More Clearly

The cornea used to be the Rodney Dangerfield of the eye. Once jokingly dismissed as a mere dust cover by scientists who study the retina, the cornea is gaining new respect as research reveals its complexities. IMPETUS FOR INTEREST: UC-Davis's Mark Mannis maintains that advances in technology and molecular and cell biology are spurring interest in cornea research. "Probably the reason for the interest, first of all, is the burgeoning technology in refractive surgery and in implantation devices

Written byRobert Finn
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

The cornea used to be the Rodney Dangerfield of the eye. Once jokingly dismissed as a mere dust cover by scientists who study the retina, the cornea is gaining new respect as research reveals its complexities.

IMPETUS FOR INTEREST: UC-Davis's Mark Mannis maintains that advances in technology and molecular and cell biology are spurring interest in cornea research. "Probably the reason for the interest, first of all, is the burgeoning technology in refractive surgery and in implantation devices," explains Mark J. Mannis, a professor of ophthalmology at the University of California, Davis, Medical Center in Sacramento, and editor-in-chief of the journal Cornea. "So on one side there's a technological impetus to increase our interest in [the] cornea. And the other is probably an enhanced understanding of molecular biology and cell biology, which is now being applied to [the] cornea, both diagnostically and therapeutically. . . . I think that the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies